Literature DB >> 23203952

Clinical outcomes of a furosemide infusion protocol in edematous patients in the intensive care unit.

George Thomsen1, Louise Bezdjian, Larissa Rodriguez, Ramona O Hopkins.   

Abstract

BACKGROUND: Many critically ill patients have severe volume overload due to vigorous fluid resuscitation. Optimal fluid management strategies to clear tissue edema are unclear.
OBJECTIVE: To assess safety and effectiveness of a clinical application of a furosemide infusion protocol in edematous critically ill patients.
METHODS: A prospective, cohort study of consecutive adult critically ill patients who received furosemide infusion by protocol from June 2003 to July 2004.
RESULTS: The mean total dose of furosemide was 2240 mg. The mean cumulative fluid balance therapy was -3376 mL. Electrolyte values in the critical laboratory range were 3.3% for potassium, 0.2% for sodium, and no critical values for magnesium. The mean change in creatinine level was +0.2 mg/dL during furosemide infusion therapy, but the mean creatinine level returned to baseline by 3 days after the furosemide infusion. A minimum mean arterial pressure less than 55 mm Hg occurred 12% of the time during the furosemide infusion.
CONCLUSIONS: Furosemide infusion therapy was associated with moderately negative cumulative fluid balances, electrolyte shifts, and mild transient worsening of renal function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23203952     DOI: 10.4037/ccn2012140

Source DB:  PubMed          Journal:  Crit Care Nurse        ISSN: 0279-5442            Impact factor:   1.708


  2 in total

1.  Vasopressin antagonist efficacy and safety in volume-overloaded critically ill patients: a new therapeutic alternative.

Authors:  Jesús Ruiz-Ramos; Paula Ramírez; María Jesús Broch; Mónica Gordon; Esther Villarreal; Armando Pinos; Manuel Sosa; Álvaro Castellanos-Ortega
Journal:  Eur J Hosp Pharm       Date:  2018-11-10

2.  Clinical effects of joint application of β-sodium aescinate and mannitol in treating early swelling after upper limb trauma surgery.

Authors:  Bin Wang; Ruixiang Yang; Qing Ju; Shaofeng Liu; Yongchun Zhang; Yong Ma
Journal:  Exp Ther Med       Date:  2016-09-22       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.